Stay updated on Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision: v3.5.0 updated on the page, replacing v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-25T20:27:31.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now displayed, replacing Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T15:19:23.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Gastric cancer is now listed as a related topic. A Genetic and Rare Diseases Information Center resources entry is shown under Resources.
    Difference
    0.2%
    Check dated 2026-02-18T04:14:24.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    A new site revision (v3.4.2) was added and a government funding status notice (v3.4.1) was removed; these appear to be maintenance updates that do not affect the study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:24:25.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    A site-wide notice about government funding delays and the NIH Clinical Center status was added. The site revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T00:49:11.000Z thumbnail image
  9. Check
    72 days ago
    Change Detected
    Summary
    Added: Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Deleted: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-27T23:46:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Paclitaxel in Gastric Cancer Clinical Trial page.